CD8A and osteosarcoma: As previously published9, high levels of CD8+ T-cell estimates were prognostic of improved EFS in osteosarcoma (log-rank test, P = 0.04; Extended Data Fig. 4b), suggesting that there is an inflammatory subset of patients with osteosarcoma prone to longer survival.